# Riluzole in Spinal Cord Injury Study

> **NCT01597518** · PHASE2,PHASE3 · TERMINATED · sponsor: **AOSpine North America Research Network** · enrollment: 193 (actual)

## Conditions studied

- Spinal Cord Injury

## Interventions

- **DRUG:** Riluzole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01597518
- **Lead sponsor:** AOSpine North America Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-10
- **Primary completion:** 2020-10-08
- **Final completion:** 2020-10-08
- **Target enrollment:** 193 (ACTUAL)
- **Why stopped:** Enrollment challenges/ slow enrollment.
- **Last updated:** 2021-04-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01597518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01597518, "Riluzole in Spinal Cord Injury Study". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT01597518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*